TRVN Trevena, Inc.

0  -1%
Previous Close 3.27
Open 3.30
Price To book 2.32
Market Cap 185.10M
Shares 57,129,000
Volume 429,706
Short Ratio 2.21
Av. Daily Volume 1,175,130

SEC filingsSee all SEC filings

  1. DEF 14A - Other definitive proxy statements 17734293
  2. 10-K - Annual report (Section 13 and 15(d), not S-K Item 405) 17675732
  3. 8-K - Current report 17673884
  4. 8-K - Current report 17664164
  5. 8-K - Current report 17623431

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 APOLLO-1 and APOLLO-2 data released February 21, 2017 - primary endpoints met but commercial doubts raised. NDA filing due 4Q 2017.
Oliceridine (TRV130)
Moderate to severe acute pain
Phase 2b endpoints not met - May 2016
Acute heart failure

Latest News

  1. Trevena to Present at the Deutsche Bank Securities 42nd Annual Healthcare Conference
  2. ETFs with exposure to Trevena, Inc. : April 7, 2017
  3. Trevena, Synergy Lead Biotech Movers
  4. Trevena Announces Presentations at the 42nd Annual Regional Anesthesiology and Acute Pain Medicine Meeting
  5. Trevena to Present at Needham & Company’s 16th Annual Healthcare Conference
  6. Lifshitz & Miller LLP Announces Investigation of Argos Therapeutics, Inc., Avid Technology, Inc., HMS Holdings Corp., Invuity, Inc., SITO Mobile, Ltd., Trevena, Inc., USANA Health Sciences, Inc. and VAALCO Energy, Inc.
  7. What Makes Trevena (TRVN) a Strong Sell?
  8. Trevena, Inc. :TRVN-US: Earnings Analysis: 2016 By the Numbers : March 16, 2017
  9. SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Trevena, Inc. (TRVN)
  10. TREVENA (TRVN) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Trevena, Inc.; Investors Encouraged to Contact Firm
  11. INVESTOR ALERT: Investigation of Trevena Announced by Holzer & Holzer, LLC
  12. Trevena to Present at the Oppenheimer 27th Annual Healthcare Conference
  13. Trevena to Present at the 2017 Barclays Global Healthcare Conference
  14. Edited Transcript of TRVN earnings conference call or presentation 8-Mar-17 1:00pm GMT
  15. Here's Why Trevena Dropped 11.8% Today
  16. Trevena reports 4Q loss
  17. Trevena Reports Full Year 2016 Earnings
  18. 3 Tempting Stocks to Avoid
  19. Trevena to Host Conference Call on March 8th to Discuss Full Year 2016 Financial Results
  20. Top Biopharma Movers of the Past Week